AI

The Series A funding announcement comes less than a month after the company announced integration capabilities with AWS, Google Cloud, Databricks and Snowflake.

The modernized, outcomes-focused AMAM is meant to help health systems keep pace with the rapid evolution of analytics technologies and artificial intelligence and "support equitable, data-driven decision-making at scale."  

SPRY Therapeutics, an AI-enabled physical therapy platform, and Every Cure, an AI-powered biotech organization, also secured funds.

The company is also recruiting a CEO in the US.

The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.

The alliance aims to streamline clinical workflows for providers by creating a suite of AI-enabled tools.

Also, Korean vision loss DTx Vivid Brain eyes global expansion.

OpenAI has launched the OpenAI Academy to support developers and companies in low- and middle-income countries who are leveraging AI to solve problems in their communities.

Also, Mediwhale raised $12 million for its United States expansion.

Also, See-Mode has received the first US FDA approval for a thyroid ultrasound analysis AI solution.